Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
JAMA|February 24, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trialMark S Sulkowski, Joseph J Eron, David Wyles, et al.Journal of Addiction Medicine|January 23, 2025
Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject DrugsElenore P Bhatraju, Judith I Tsui, Moonseong Heo, et al.International Immunology|June 15, 2006
T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamilyMathias Lichterfeld, Katie L Williams, Stanley K Mui, et al.Journal of the International AIDS Society|September 7, 2023
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT studyJoanne M Carson, Sebastiano Barbieri, Evan Cunningham, et al.Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 31, 2019
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planningEmily Bethea, Ashwini Arvind, Jenna Gustafson, et al.Journal of the American Heart Association|September 21, 2022
Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus CoinfectionRaynell Lang, Elizabeth Humes, Brenna Hogan, et al.Open Forum Infectious Diseases|September 2, 2025
Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment GapRaynell Lang, Elizabeth Humes, Asya Lyass, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2021
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort StudyVivek Naranbhai, Claire A Pernat, Alexander Gavralidis, et al.Annals of Internal Medicine|September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons LearnedRoy M Gulick, Alice K Pau, Eric Daar, et al.Pageof 5